|
Hernández-Romero D, Marín F, Roldán V, Lip GY. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients. J Intern Med. 2012 Oct;272(4):409. doi: 10.1111/j.1365-2796.2012.02565.x. Epub 2012 Jul 27. PubMed PMID: 22702474.
AÑO: 2012; IF: 6.455
|
22702474
|
Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish. PubMed PMID: 22609214.
AÑO: 2012; IF: 3.204
|
|
Hernández-Romero D, García-Salas JM, López-Cuenca A, Pérez-Berbel P, Puche C, Casas T, Orenes-Piñero E, Manzano-Fernández S, Valdés M, Marín F. High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS. ScientificWorldJournal. 2012;2012:578616. doi: 10.1100/2012/578616. Epub 2012 Jan 4. PubMed PMID: 22262955; PubMed Central PMCID: PMC3259501.
AÑO: 2012; IF: 1.73
|
|
Jover E, Hernández-Romero D, Hurtado JA, Romero-Aniorte AI, Casas T, Valdés M. Serum adiponectin level as a biomarker of coronary artery calcification and severe coronary lesions. Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):1060-1. doi: 10.1016/j.recesp.2012.03.031. Epub 2012 Sep 7. English, Spanish. PubMed PMID: 22964061.
AÑO: 2012; IF: 3.204
|
|
Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011 Jun 21;57(25):2496-504. doi: 10.1016/j.jacc.2010.12.033. Epub 2011 Apr 14. PubMed PMID: 21497043.
AÑO: 2011; IF: 14.156
|